A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret prostate-specific antigen (PSA) test results compared to existing models.

Retinoic acid suppresses immune defenses against cancer, but a new drug KyA33 boosts vaccine success and slows tumor growth ...

Increased use of organoids in cancer research: The Würzburg lighthouse project "Preclinical Models" is working towards this ...

Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.

Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...

A study that was published in recent weeks has given the world a sobering view of the number of cancer diagnoses that are ...

NEW YORK, Jan. 12, 2026 /PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) announced today that its 2026 funding opportunities are officially open for applications.

Scientists have uncovered how a vitamin A metabolite can suppress anti-cancer immunity. Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have uncovered new ...

Men with newly diagnosed multiple myeloma are twice as likely as women to have stage III disease, with more kidney damage and ...

A new drug candidate shows promise by reversing cognitive decline in advanced Alzheimer's disease by restoring brain balance ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its ...

Inside the race to turn one of cell biology’s least understood processes into a new foundation for drug development and ...